PHGE Spending and interest coverage

BiomX Inc. (PHGE) Spending and interest coverage

R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

Metric	Value	Formula and calculation
R&D / revenue · 12 months	(m)	Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m).
Stock-based compensation / revenue · 12 months	(m)	Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m).
Interest coverage · 12 months	(m)	Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m).

Calculation inputs

Input	Amount with unit	Raw financial data
Research and development spending	(m)	Research and Development Expense
Revenue	(m)
Stock-based compensation	2.79M USD	Share-based Payment Arrangement, Noncash Expense
Operating income	-32.99M USD	Operating Income (Loss)
Interest expense · reported / estimated	(m)	Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period ending	Research and development spending (USD)	Revenue (USD)	Stock-based compensation (USD)	Operating income (USD)	Interest expense · reported / estimated (USD)	R&D / revenue	SBC / revenue	Interest coverage	Interest expense basis
2026-06-30	(m)	(m)	$2.79M	$-32.99M	(m)	(m)	(m)	(m)	(m)
2026-03-31	(m)	(m)	$-496.00K	$-35.01M	(m)	(m)	(m)	(m)	(m)
2025-12-31	$21.29M	(m)	$2.09M	$-41.47M	(m)	(m)	(m)	(m)	(m)
2025-09-30	$22.77M	(m)	$2.56M	$-40.41M	(m)	(m)	(m)	(m)	(m)
2025-06-30	$23.93M	(m)	$2.95M	$-43.20M	(m)	(m)	(m)	(m)	(m)
2025-03-31	$25.81M	(m)	$2.33M	$-45.49M	(m)	(m)	(m)	(m)	(m)
2024-12-31	$24.66M	(m)	$1.85M	$-44.52M	(m)	(m)	(m)	(m)	(m)
2024-09-30	$20.96M	(m)	$1.50M	$-33.11M	$1.37M	(m)	(m)	-24.17×	Reported
2024-06-30	$19.32M	(m)	$867.00K	$-29.58M	$1.94M	(m)	(m)	-15.21×	Reported
2024-03-31	$16.24M	(m)	$1.06M	$-25.93M	$2.69M	(m)	(m)	-9.64×	Reported
2023-12-31	$16.70M	(m)	$1.06M	$-25.35M	$2.40M	(m)	(m)	-10.54×	Reported
2023-09-30	$17.22M	(m)	$1.01M	$-25.64M	$2.45M	(m)	(m)	-10.47×	Reported
2023-06-30	$15.11M	(m)	$1.18M	$-24.39M	$2.43M	(m)	(m)	-10.04×	Reported
2023-03-31	$15.88M	(m)	$1.09M	$-25.64M	$2.17M	(m)	(m)	-11.80×	Reported
2022-12-31	$16.24M	(m)	$1.53M	$-27.22M	$2.07M	(m)	(m)	-13.16×	Reported
2022-09-30	$19.62M	(m)	$1.75M	$-31.44M	$1.97M	(m)	(m)	-16.00×	Reported
2022-06-30	$22.70M	(m)	$2.41M	$-34.73M	(m)	(m)	(m)	(m)	(m)
2022-03-31	$21.93M	(m)	$3.32M	$-34.71M	(m)	(m)	(m)	(m)	(m)
2021-12-31	$22.68M	(m)	$3.24M	$-35.46M	$983.00K	(m)	(m)	-36.08×	Reported
2021-09-30	$23.73M	(m)	$3.41M	$-34.74M	(m)	(m)	(m)	(m)	(m)
2021-06-30	$23.18M	(m)	$3.50M	$-33.74M	(m)	(m)	(m)	(m)	(m)
2021-03-31	$23.20M	(m)	$3.08M	$-32.96M	(m)	(m)	(m)	(m)	(m)
2020-12-31	$20.93M	(m)	$2.89M	$-30.26M	(m)	(m)	(m)	(m)	(m)
2020-09-30	$19.47M	(m)	$2.19M	$-30.95M	(m)	(m)	(m)	(m)	(m)
2020-06-30	$15.89M	(m)	$1.32M	$-26.78M	(m)	(m)	(m)	(m)	(m)
2020-03-31	$14.65M	(m)	$971.00K	$-24.45M	(m)	(m)	(m)	(m)	(m)
2019-12-31	$13.49M	(m)	$938.00K	$-22.21M	(m)	(m)	(m)	(m)	(m)
2019-09-30	(m)	(m)	(m)	$-1.02M	(m)	(m)	(m)	(m)	(m)
2019-06-30	(m)	(m)	(m)	$-404.52K	(m)	(m)	(m)	(m)	(m)
2019-03-31	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-12-31	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Intellicheck, Inc. (IDN)	United States	$0.049B	26.37
PIXELWORKS, INC (PXLW)	United States	$0.044B
Aether Holdings, Inc. (ATHR)	United States	$0.043B	-11.40
Where Food Comes From, Inc. (WFCF)	United States	$0.055B
Skillsoft Corp. (SKIL)	United States	$0.056B	-0.39
NETSOL TECHNOLOGIES INC (NTWK)	United States	$0.056B	23.14
Advasa Holdings, Inc. (ADBT)		$0.060B
Airship AI Holdings, Inc. (AISP)	United States	$0.065B	3.15
Sports Entertainment Gaming Global Corp (SEGG)	United States	$0.066B	-0.25
Great Elm Group, Inc. (GEG)	United States	$0.067B	-1.76